Furthermore, dioscin was effective in suppressing the TLR4/MyD88/NF-κB signaling pathway to inhibit HSCs activation and reduce ECM accumulation for attenuating liver fibrosis in vivo and in vitro. This evidence concerns the gene TLR4 and Hepatic fibrosis.